Operating Expenses Summary of Thyrocare Technologies Limited

Thyrocare Technologies Limited's latest annual operating expenses in 2023 was 1.59 Billion INR , down -43.32% from previous year.
Thyrocare Technologies Limited's latest quarterly operating expenses in 2024 Q2 was 911.5 Million INR , up 21.2% from previous quarter.
Thyrocare Technologies Limited reported a annual operating expenses of 2.82 Billion INR in annual operating expenses 2022, up 29.31% from previous year.
Thyrocare Technologies Limited reported a annual operating expenses of 2.18 Billion INR in annual operating expenses 2021, up 15.06% from previous year.
Thyrocare Technologies Limited reported a quarterly operating expenses of 400.9 Million INR for 2024 Q1, down -15.24% from previous quarter.
Thyrocare Technologies Limited reported a quarterly operating expenses of 473 Million INR for 2023 Q4, down -39.51% from previous quarter.

Annual Operating Expenses Chart of Thyrocare Technologies Limited (2023 - 2012)

Historical Annual Operating Expenses of Thyrocare Technologies Limited (2023 - 2012)

Year	Operating Expenses	Operating Expenses Growth
2023	1.59 Billion INR	-43.32%
2022	2.82 Billion INR	29.31%
2021	2.18 Billion INR	15.06%
2020	1.89 Billion INR	8.03%
2019	1.75 Billion INR	6.82%
2018	1.64 Billion INR	21.72%
2017	1.34 Billion INR	15.71%
2016	1.16 Billion INR	30.35%
2015	894.91 Million INR	39.38%
2014	642.06 Million INR	122.55%
2013	288.49 Million INR	99.89%
2012	144.32 Million INR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	911.5 Million INR	21.2%
2024 Q1	400.9 Million INR	-15.24%
2023 Q4	473 Million INR	-39.51%
2023 Q1	719.4 Million INR	-10.34%
2023 FY	1.59 Billion INR	-43.32%
2023 Q3	782 Million INR	0.92%
2023 Q2	774.9 Million INR	7.71%
2022 Q2	714.2 Million INR	17.12%
2022 Q4	802.4 Million INR	15.52%
2022 FY	2.82 Billion INR	29.31%
2022 Q1	609.8 Million INR	0.38%
2022 Q3	694.6 Million INR	-2.74%
2021 Q3	594 Million INR	15.41%
2021 Q2	514.7 Million INR	11.0%
2021 Q1	463.7 Million INR	-21.18%
2021 FY	2.18 Billion INR	15.06%
2021 Q4	607.5 Million INR	2.27%
2020 Q4	588.3 Million INR	9.37%
2020 FY	1.89 Billion INR	8.03%
2020 Q3	537.9 Million INR	11.74%
2020 Q2	481.4 Million INR	67.04%
2020 Q1	288.2 Million INR	-44.0%
2019 FY	1.75 Billion INR	6.82%
2019 Q1	406.1 Million INR	-14.43%
2019 Q2	411 Million INR	1.21%
2019 Q3	423.3 Million INR	2.99%
2019 Q4	514.6 Million INR	21.57%
2018 Q3	417.1 Million INR	6.7%
2018 FY	1.64 Billion INR	21.72%
2018 Q2	390.9 Million INR	8.49%
2018 Q1	360.3 Million INR	-7.76%
2018 Q4	474.6 Million INR	13.79%
2017 FY	1.34 Billion INR	15.71%
2017 Q4	390.63 Million INR	33.81%
2017 Q3	291.92 Million INR	5.43%
2017 Q2	276.89 Million INR	-17.16%
2017 Q1	334.23 Million INR	-2.07%
2016 Q3	286.07 Million INR	14.91%
2016 Q2	248.96 Million INR	5.84%
2016 Q1	235.23 Million INR	18.67%
2016 Q4	341.3 Million INR	19.31%
2016 FY	1.16 Billion INR	30.35%
2015 Q4	198.22 Million INR	-16.12%
2015 Q2	193.62 Million INR	-15.64%
2015 Q1	229.52 Million INR	0.0%
2015 FY	894.91 Million INR	39.38%
2015 Q3	236.3 Million INR	22.04%
2014 FY	642.06 Million INR	122.55%
2013 FY	288.49 Million INR	99.89%
2012 FY	144.32 Million INR	0.0%

Peer Operating Expenses Comparison of Thyrocare Technologies Limited

Name	Operating Expenses	Operating Expenses Difference
Krsnaa Diagnostics Limited	1.33 Billion INR	-19.798%
Dr. Lal PathLabs Limited	4.13 Billion INR	61.335%
Metropolis Healthcare Limited	3.3 Billion INR	51.563%
Vijaya Diagnostic Centre Limited	985.79 Million INR	-62.194%
Vimta Labs Limited	1.05 Billion INR	-51.192%

Global Stocks Search

Thyrocare Technologies Limited (THYROCARE.NS)

Operating Expenses Summary of Thyrocare Technologies Limited

Annual Operating Expenses Chart of Thyrocare Technologies Limited (2023 - 2012)

Historical Annual Operating Expenses of Thyrocare Technologies Limited (2023 - 2012)

Peer Operating Expenses Comparison of Thyrocare Technologies Limited